BioXcel Therapeutics Inc #IPO Preview ( $BTAI )
Company: BioXcel Therapeutics, Inc. Symbol: BTAI Description: They are a clinical stage biopharmaceutical company focused on drug development that utilizes novel artificial intelligence, or AI, to identify the next wave of medicines across neuroscience and immuno-oncology. Trade Date: 3/8 Shares: 5 million Price Range: $11.00-$13.00 Underwriter(s): Barclays, UBS Investment Bank, BMO Capital Markets Co-Manager(s): Canaccord[…]
